Review



recombinant human il 2 protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress recombinant human il 2 protein
    Recombinant Human Il 2 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/IL-2%2C+Human/pmc13389675-136-27-31
    Average 93 stars, based on 6 article reviews
    recombinant human il 2 protein - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Concentration Assay:

    Article Title: Baicalin circumvents anti-PD-1 resistance by regulating the gut microbiota metabolite short-chain fatty acids.
    Article Snippet: .. A cell concentration of 3 × 106 cells/mL was used in RPMI 1640 medium supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (200 U/mL, HY-P7077, MCE, China) for 24 h. Naive CD4+ T cells were cultured and stimulated in a 24-well plate with anti-CD3 (4 μg/mL) and anti-CD28 (2 μg/ mL) antibodies at a concentration of 3 × 106 cells/mL in RPMI 1640 medium containing 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (100 U/mL) for 5 days. .. On day 3, 0.5 mL lymphocyte culture medium with the cytokines IL-2 (20 ng/mL) and TGFβ1 (5 ng/mL, HY-P7427, MCE, China) were added.

    Recombinant:

    Article Title: Baicalin circumvents anti-PD-1 resistance by regulating the gut microbiota metabolite short-chain fatty acids.
    Article Snippet: .. A cell concentration of 3 × 106 cells/mL was used in RPMI 1640 medium supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (200 U/mL, HY-P7077, MCE, China) for 24 h. Naive CD4+ T cells were cultured and stimulated in a 24-well plate with anti-CD3 (4 μg/mL) and anti-CD28 (2 μg/ mL) antibodies at a concentration of 3 × 106 cells/mL in RPMI 1640 medium containing 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (100 U/mL) for 5 days. .. On day 3, 0.5 mL lymphocyte culture medium with the cytokines IL-2 (20 ng/mL) and TGFβ1 (5 ng/mL, HY-P7427, MCE, China) were added.

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression
    Article Snippet: CD8 + T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8 + T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 h. Following activation, the T cells were subjected to a two-day culture in Huh7-conditioned medium. ..

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression.
    Article Snippet: Flow cytometry for T cell phenotyping CD8+ T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8+ T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 hours. ..

    Article Title: De novo design of mini-binder proteins against IL-2 receptor β chain.
    Article Snippet: IL-2 regulates the immune response by interacting with different IL-2 receptor (IL-2R) subunits.. High dose of IL-2 binds to IL-2Rβγc heterodimer, which induce various side effects while activating immune function.. Disrupting IL-2 and IL-2R interactions can block IL-2 mediated immune response.

    Cell Culture:

    Article Title: Baicalin circumvents anti-PD-1 resistance by regulating the gut microbiota metabolite short-chain fatty acids.
    Article Snippet: .. A cell concentration of 3 × 106 cells/mL was used in RPMI 1640 medium supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (200 U/mL, HY-P7077, MCE, China) for 24 h. Naive CD4+ T cells were cultured and stimulated in a 24-well plate with anti-CD3 (4 μg/mL) and anti-CD28 (2 μg/ mL) antibodies at a concentration of 3 × 106 cells/mL in RPMI 1640 medium containing 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and recombinant IL-2 (100 U/mL) for 5 days. .. On day 3, 0.5 mL lymphocyte culture medium with the cytokines IL-2 (20 ng/mL) and TGFβ1 (5 ng/mL, HY-P7427, MCE, China) were added.

    Purification:

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression
    Article Snippet: CD8 + T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8 + T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 h. Following activation, the T cells were subjected to a two-day culture in Huh7-conditioned medium. ..

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression.
    Article Snippet: Flow cytometry for T cell phenotyping CD8+ T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8+ T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 hours. ..

    In Vitro:

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression
    Article Snippet: CD8 + T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8 + T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 h. Following activation, the T cells were subjected to a two-day culture in Huh7-conditioned medium. ..

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression.
    Article Snippet: Flow cytometry for T cell phenotyping CD8+ T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8+ T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 hours. ..

    Activation Assay:

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression
    Article Snippet: CD8 + T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8 + T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 h. Following activation, the T cells were subjected to a two-day culture in Huh7-conditioned medium. ..

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression.
    Article Snippet: Flow cytometry for T cell phenotyping CD8+ T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8+ T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 hours. ..

    Magnetic Beads:

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression
    Article Snippet: CD8 + T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8 + T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 h. Following activation, the T cells were subjected to a two-day culture in Huh7-conditioned medium. ..

    Article Title: A novel integrative machine learning-based prognostic model reveals lactylation regulation in hepatocellular carcinoma progression.
    Article Snippet: Flow cytometry for T cell phenotyping CD8+ T cells were isolated from human peripheral blood mononuclear cells (PBMCs) using CD8 MicroBeads, human (130-045-201, Miltenyi). .. The purified CD8+ T cells were then activated in vitro by co-culture with Human CD3/CD28 T Cell Activation Magnetic Beads (HY-K0353, MedChemExpress) and recombinant IL-2 (HY-P7037, MedChemExpress) for 72 hours. ..



    Similar Products

    recombinant human il 2 protein  (MedChemExpress)
    93
    MedChemExpress recombinant human il 2 protein
    Recombinant Human Il 2 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/IL-2%2C+Human/pmc13389675-136-27-31
    Average 93 stars, based on 1 article reviews
    recombinant human il 2 protein - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    recombinant human il 2  (Miltenyi Biotec)
    96
    Miltenyi Biotec recombinant human il 2
    Recombinant Human Il 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/Human+IL-2+IS%2C+research+grade/pm42447864-743-33-36
    Average 96 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    recombinant human il 2  (ABclonal Biotechnology)
    94
    ABclonal Biotechnology recombinant human il 2
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Recombinant Human Il 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/Recombinant+Human+IL2+Protein/pmc13460283-253-0-5
    Average 94 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    recombinant mouse il-2 protein  (Bio-Techne corporation)
    97
    Bio-Techne corporation recombinant mouse il-2 protein
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Recombinant Mouse Il 2 Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/Recombinant+Mouse+IL-2+Protein/bio-techne+corporation___402-ml
    Average 97 stars, based on 1 article reviews
    recombinant mouse il-2 protein - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    medium  (Miltenyi Biotec)
    94
    Miltenyi Biotec medium
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Medium, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/MACS+GMP+Recombinant+Human+IL-2/us12668640-299-2-10
    Average 94 stars, based on 1 article reviews
    medium - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    recombinant human il 2  (Novoprotein)
    86
    Novoprotein recombinant human il 2
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Recombinant Human Il 2, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/2+human+il+recombinant/pm42284413-250-60-66
    Average 86 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    recombinant il 2 ril 2  (Miltenyi Biotec)
    96
    Miltenyi Biotec recombinant il 2 ril 2
    Plasma <t>level</t> <t>IL-2</t> in control (n=37) and PMOS (n=37) subjects and altered gene expression of JAKs in the total leukocyte RNA of 102 control and 102 PMOS subjects. A: Dot plot graphical representation of IL-2 level in the control and PMOS subjects. B-D: Dot and violin plot graphical representation of real-time gene expression level in JAK1, JAK2 and JAK3 . Each dot represents an individual subject. Each reaction was performed in triplicates and the ΔCt method was used to calculate the gene expression difference between control and PMOS subjects. 2 −ΔCt values of each subject are plotted on the Y-axis of the graph. Unpaired student’s T-tests were performed using GraphPad Prism 8 and p-value< 0.05 were set to be significant. Graph E and F: Dot and bar graph representation of relative gene expression level of JAK1, and JAK2 among the control and PMOS phenotype A, B, C, and D. The control group represented black dots, phenotype A in blue dots, phenotype B in orange dots, phenotype C in violet dots and phenotype D in yellow dots. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were set to be statistically significant.
    Recombinant Il 2 Ril 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/Human+IL-2+IS%2C+research+grade/med_rxiv__64898__2026__05__30__26354518-212-13-17
    Average 96 stars, based on 1 article reviews
    recombinant il 2 ril 2 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    recombinant il 2  (Novartis)
    86
    Novartis recombinant il 2
    Plasma <t>level</t> <t>IL-2</t> in control (n=37) and PMOS (n=37) subjects and altered gene expression of JAKs in the total leukocyte RNA of 102 control and 102 PMOS subjects. A: Dot plot graphical representation of IL-2 level in the control and PMOS subjects. B-D: Dot and violin plot graphical representation of real-time gene expression level in JAK1, JAK2 and JAK3 . Each dot represents an individual subject. Each reaction was performed in triplicates and the ΔCt method was used to calculate the gene expression difference between control and PMOS subjects. 2 −ΔCt values of each subject are plotted on the Y-axis of the graph. Unpaired student’s T-tests were performed using GraphPad Prism 8 and p-value< 0.05 were set to be significant. Graph E and F: Dot and bar graph representation of relative gene expression level of JAK1, and JAK2 among the control and PMOS phenotype A, B, C, and D. The control group represented black dots, phenotype A in blue dots, phenotype B in orange dots, phenotype C in violet dots and phenotype D in yellow dots. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were set to be statistically significant.
    Recombinant Il 2, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/2+human+il/10__1016_slash_j__imbio__2026__153205-131-0-5
    Average 86 stars, based on 1 article reviews
    recombinant il 2 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    recombinant human il 2  (Procell Inc)
    86
    Procell Inc recombinant human il 2
    Plasma <t>level</t> <t>IL-2</t> in control (n=37) and PMOS (n=37) subjects and altered gene expression of JAKs in the total leukocyte RNA of 102 control and 102 PMOS subjects. A: Dot plot graphical representation of IL-2 level in the control and PMOS subjects. B-D: Dot and violin plot graphical representation of real-time gene expression level in JAK1, JAK2 and JAK3 . Each dot represents an individual subject. Each reaction was performed in triplicates and the ΔCt method was used to calculate the gene expression difference between control and PMOS subjects. 2 −ΔCt values of each subject are plotted on the Y-axis of the graph. Unpaired student’s T-tests were performed using GraphPad Prism 8 and p-value< 0.05 were set to be significant. Graph E and F: Dot and bar graph representation of relative gene expression level of JAK1, and JAK2 among the control and PMOS phenotype A, B, C, and D. The control group represented black dots, phenotype A in blue dots, phenotype B in orange dots, phenotype C in violet dots and phenotype D in yellow dots. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were set to be statistically significant.
    Recombinant Human Il 2, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+il+2/epidermal+factor+growth/pm42168330-416-0-5
    Average 86 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined by IL‐2 production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.

    Journal: Advanced Science

    Article Title: Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy

    doi: 10.1002/advs.77020

    Figure Lengend Snippet: Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined by IL‐2 production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.

    Article Snippet: Recombinant human IL‐2 (Cat# RP01039, ABclonal) was added at a final concentration of 100 Unit/mL −1 to expand T cells.

    Techniques: Flow Cytometry, Activation Assay, Expressing, Transduction, Cell Culture, Activity Assay, Concentration Assay, Plasmid Preparation

    Plasma level IL-2 in control (n=37) and PMOS (n=37) subjects and altered gene expression of JAKs in the total leukocyte RNA of 102 control and 102 PMOS subjects. A: Dot plot graphical representation of IL-2 level in the control and PMOS subjects. B-D: Dot and violin plot graphical representation of real-time gene expression level in JAK1, JAK2 and JAK3 . Each dot represents an individual subject. Each reaction was performed in triplicates and the ΔCt method was used to calculate the gene expression difference between control and PMOS subjects. 2 −ΔCt values of each subject are plotted on the Y-axis of the graph. Unpaired student’s T-tests were performed using GraphPad Prism 8 and p-value< 0.05 were set to be significant. Graph E and F: Dot and bar graph representation of relative gene expression level of JAK1, and JAK2 among the control and PMOS phenotype A, B, C, and D. The control group represented black dots, phenotype A in blue dots, phenotype B in orange dots, phenotype C in violet dots and phenotype D in yellow dots. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were set to be statistically significant.

    Journal: medRxiv

    Article Title: Targeting PTP1B and DUSP4 phosphatases to Boost Tregs: A Novel Therapy for Polyendocrine Metabolic Ovarian Syndrome (PMOS) Immune Dysfunction

    doi: 10.64898/2026.05.30.26354518

    Figure Lengend Snippet: Plasma level IL-2 in control (n=37) and PMOS (n=37) subjects and altered gene expression of JAKs in the total leukocyte RNA of 102 control and 102 PMOS subjects. A: Dot plot graphical representation of IL-2 level in the control and PMOS subjects. B-D: Dot and violin plot graphical representation of real-time gene expression level in JAK1, JAK2 and JAK3 . Each dot represents an individual subject. Each reaction was performed in triplicates and the ΔCt method was used to calculate the gene expression difference between control and PMOS subjects. 2 −ΔCt values of each subject are plotted on the Y-axis of the graph. Unpaired student’s T-tests were performed using GraphPad Prism 8 and p-value< 0.05 were set to be significant. Graph E and F: Dot and bar graph representation of relative gene expression level of JAK1, and JAK2 among the control and PMOS phenotype A, B, C, and D. The control group represented black dots, phenotype A in blue dots, phenotype B in orange dots, phenotype C in violet dots and phenotype D in yellow dots. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were set to be statistically significant.

    Article Snippet: After 24 hours of siRNA treatment, the cells were stimulated with 300IU of recombinant IL-2 (rIL-2) (#130-097-743, Miltenyi Biotech, Germany).

    Techniques: Clinical Proteomics, Control, Gene Expression

    FACS analysis showed an increase of CD4 +ve CD25 +ve CD127 low/- Treg population after PTP1B and DUSP4 (MKP-2) siRNA-based knockdown in PBMCs of PMOS (n=12) subjects. A: bar graph representation showing the gene expression of PTP1B and DUSP4 across the PTP1B, DUSP4, and both silenced PBMCs. B: Dot plot and histogram representation of gating strategy with P1 shows lymphocyte population, P2 shows CD4-FITC +ve population, P3 shows CD25-PE Cy7 +ve population and P4 shows CD127 low/- Treg population. Gating is based on histogram of unstained and stained population (FITC, PE Cy7 and Alexa Fluor 647 respectively). C: Dot plot representation of CD4-FITC +ve CD25-PECy7 +ve CD127-Alexa Fluor 647 low/- (P4) Treg population of all treatment conditions including; untreated, IL-2 treated, control siRNA silenced, control siRNA silenced with IL-2, PTP1B siRNA silenced without IL-2 and with IL-2, DUSP4 siRNA silenced without IL-2 and with IL-2, and PTP1B+DUSP4 siRNA silenced without IL-2 and with IL-2. D: Dot and truncated violin plot representation of the percentage of CD4 +ve CD25 +ve CD127 low/- Treg population in lymphocyte events across all the treatments. Each dot represents an individual subject. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were considered as statistically significant.

    Journal: medRxiv

    Article Title: Targeting PTP1B and DUSP4 phosphatases to Boost Tregs: A Novel Therapy for Polyendocrine Metabolic Ovarian Syndrome (PMOS) Immune Dysfunction

    doi: 10.64898/2026.05.30.26354518

    Figure Lengend Snippet: FACS analysis showed an increase of CD4 +ve CD25 +ve CD127 low/- Treg population after PTP1B and DUSP4 (MKP-2) siRNA-based knockdown in PBMCs of PMOS (n=12) subjects. A: bar graph representation showing the gene expression of PTP1B and DUSP4 across the PTP1B, DUSP4, and both silenced PBMCs. B: Dot plot and histogram representation of gating strategy with P1 shows lymphocyte population, P2 shows CD4-FITC +ve population, P3 shows CD25-PE Cy7 +ve population and P4 shows CD127 low/- Treg population. Gating is based on histogram of unstained and stained population (FITC, PE Cy7 and Alexa Fluor 647 respectively). C: Dot plot representation of CD4-FITC +ve CD25-PECy7 +ve CD127-Alexa Fluor 647 low/- (P4) Treg population of all treatment conditions including; untreated, IL-2 treated, control siRNA silenced, control siRNA silenced with IL-2, PTP1B siRNA silenced without IL-2 and with IL-2, DUSP4 siRNA silenced without IL-2 and with IL-2, and PTP1B+DUSP4 siRNA silenced without IL-2 and with IL-2. D: Dot and truncated violin plot representation of the percentage of CD4 +ve CD25 +ve CD127 low/- Treg population in lymphocyte events across all the treatments. Each dot represents an individual subject. One-way ANOVA was performed using GraphPad Prism 8 and p-value< 0.05 were considered as statistically significant.

    Article Snippet: After 24 hours of siRNA treatment, the cells were stimulated with 300IU of recombinant IL-2 (rIL-2) (#130-097-743, Miltenyi Biotech, Germany).

    Techniques: Knockdown, Gene Expression, Staining, Control